Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers December 16, 2018
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - December 16, 2018

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

12/16/18 - Clyburn has taken more than $1 million in pharma money in a decade, far surpassing peers
Jim Clyburn, D-Columbia, has collected more in the last decade from powerful political action committees attached to the pharmaceutical industry than anyone else in the House or Senate, according to Kaiser Health News and a Post and Courier analysis. During that time, he has brought in more than $1 million in campaign contributions from an industry
12/16/18 - Guest commentary
Leslie told me the medication his daughter needs to live costs $45,000 per vial, when it only costs $200 in Canada. Stephen told me that his wife s insulin costs $465 per refill, when it costs just $62.50 in Canada. If $200 or $62.50 or any lower price is a sufficient price to pay in Canada, then those lower prices are sufficient in America.
12/16/18 - In LUTH, emergency C-section is routine
?Doctors perform four surgeries in 12 hours. Obstetrical emergencies are life-threatening medical conditions that occur in pregnancy or during or after labour and delivery. Cross section of Medical doctors carrying out Fistula surgery inside the operating theatre of the Usmanu Danfodiyo Teaching Hospital, Sokoto.
12/16/18 - Israeli drug giant Teva to move offices to Tel Aviv [Jerusalem Post (Israel)]
"The expected move-in date will be mid-2020," Teva SVP global human resources Mark Sabag told Globes. Israeli drug giant Teva Pharmaceutical Industries Ltd. will move its global headquarter offices from Petah Tikva to Ramat Hahayal neighborhood in Tel Aviv according to a report by Globes. "The expected move-in date will be mid-2020," Teva SVP glob
12/16/18 - KAUST launches first vaccine manufacturing, development center in Middle East [Al Riyadh (Saudi Arabia)]
King Abdullah University of Science and Technology launched yesterday the Saudi Center for Manufacturing and Developing Medical Vaccine Proteins. The project, the first of its kind in the Middle East, will be established in partnership with Research Products Development Co. and SaudiVax. The center will manufacture vaccines, which will be the first
12/16/18 - KAUST launches first vaccine manufacturing, development center in Middle East [Saudi Press Agency (Saudi Arabia)]
Jeddah, 16 December, 2018, SPA King Abdullah University of Science and Technology launched yesterday the Saudi Center for Manufacturing and Developing Medical Vaccine Proteins. The project, the first of its kind in the Middle East, will be established in partnership with Research Products Development Co. and SaudiVax. The center will manufacture
12/16/18 - Opioid crisis on the docket for Lee County Commissioners [The Sanford Herald, N.C.]
The meeting starts at 6 p.m. at the Lee County Government Center at 106 Hillcrest Drive, Sanford. According to the agenda, the board will consider adopting a resolution declaring opioids a public health nuisance in response to the statewide opioid litigation against pharmaceutical companies, including one lawsuit against Purdue Pharma filed by the
12/16/18 - Tadalafil - In The Indication Pulmonary Arterial Hypertension [TendersInfo (India)]
Contract notice: tadalafil- in the indication pulmonary arterial hypertension. Conclusion of non-exclusive rebate agreements pursuant to 130 a sgb v on medicines containing the active substance tadalafil with the possibility of termination at any time within the scope of a so-called "open-house model". a contract is signed with each pharmaceutical.
12/15/18 - Alder BioPharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Tehran Times (Iran)]
-Alder BioPharmaceuticals, Inc., a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today reported that the Compensation Committee of Alders Board of Directors granted a non-qualified stock option to purchase an aggregate of 270,000 shares of Alders common stock to Carlos E. Campoy under Al
12/15/18 - AstraZeneca mines for positives in Imfinzi`s failed Mystic lung cancer trial [Syrian Arab News Agency]
AstraZeneca felt the blow last month when Mystic, a key trial examining its immuno-oncology drug Imfinzi in previously untreated lung cancer, failed. As executives were quick to point out, there was clear clinical benefit of Imfinzi monotherapy compared with the standard of care in the phase 3 trial, which featured patients whose tumors expressed p
12/15/18 - BeiGene Announces Updated Phase 1A/1B Data on Tislelizumab Presented at the European Society for Medical Oncology Immuno-Oncology Congress
BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, announced that updated clinical data from an ongoing Phase 1 A/1B trial of tislelizumab, an investigational anti-PD-1 antibody, were presented in an oral...
12/15/18 - Bellicum Reports Safety Results and Promising Activity of Its Controlled CAR-T Candidate BPX-601 in Patients with Advanced Pancreatic Cancer at ESMO-IO [Tehran Times (Iran)]
-Bellicum Pharmaceuticals, Inc., a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today reported safety and promising activity of BPX-601 in Part 1 of a Phase 1/ 2 dose-escalation study in patients with advanced, metastatic pancreatic cancer expressing PSCA. Data were reviewed dur
12/15/18 - Bevacizumab Biosimilar, IBI305, Meets Primary End Points in 2 Clinical Trials [T-break Tech (Middle East)]
"Lung cancer is the highest incidence cancer in China, and bevacizumab is an important treatment for non-small lung cancer patients. The launch of a high-quality bevacizumab biosimilar will improve drug accessibility and benefit more patients, "said Li Zhang, MD, from the cancer hospital of Sun Yat-Sen University, in a statement announcing the posi
12/15/18 - Bovine Blood Plasma Derivatives Market Will Increment at a Notable CAGR of 5.8% During the Forecast Period of 2017 to 2025
Albany, NY 12/14/2018 Global Bovine Blood Plasma Derivatives Market: Snapshot. Bovine blood plasma derivatives are exclusive in a way when it comes to delivering palatability, something that cannot be achieved via other alternatives such as plant extracted proteins and other synthetic nutrient elements. The analysts of the report have evaluat
12/15/18 - Butantan Institute and MSD agree to collaborate on dengue vaccine development [T-break Tech (Middle East)]
Brazil`s Butantan Institute signed a collaboration agreement with Merck Sharp& Dohme to develop dengue vaccines. The vaccine developed by Butantan Institute with So Paulo Research Foundation- FAPESP`s support is currently in the last phase of trials involving humans, with 17,000 volunteers participating. The agreement also allows for exclusive...
12/15/18 - Cerveau Technologies, Inc. to Support a First Clinical Study in Asia of a Novel Biomarker of Alzheimers Disease [Syrian Arab News Agency]
Cerveau Technologies Inc. today announced that the Memory Aging and Cognition Centre at the National University Health System in Singapore has initiated a study with an early stage imaging agent MK-6240 to be used in Positron Emission Tomography scans for assessing the level and progression of neurofibrillary tangles in the brain.
12/15/18 - Conclusion Of A Non-exclusive Rebate Agreement Pursuant To Section 130a (8) Sgb V On Medicines Containing The Active Substance Aripiprazole As Depot Injection Suspension (atc Code: N05ax12) [TendersInfo (India)]
The aok- the health fund for lower saxony intends until the entry into force of exclusive contracts after a public tender according to the regulations of the 4th part of the gwb, non-exclusive drug discount agreements on the active ingredient aripiprazole as depot injection suspension with all possible market participants in the so-called "open-hou
12/15/18 - Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a (8) Sgb V On Medicines Containing The Active Substance Pegfilgrastim (atc: L03aa13) As Part Of A So-called Open-house Model. [TendersInfo (India)]
For the active substance pegfilgrastim, the aok rheinland-pfalz/ saarland- die gesundheitskasse offers rebate contracts to all interested pharmaceutical companies without a selection decision for the period up to the entry into force of exclusive contracts following a formal award procedure in accordance with the regulations of the 4th part of the
12/15/18 - CYNATA Gets Major Funding From NHMRC For Second Phase Clinical Trial In Osteoarthritis [Sport360]
Australian National Health and Medical Research Council will fund a major second phase of clinical trial in osteoarthritis for CYNATA THERAPEUTICS LIMITED. Cynata being a biotechnology company has its specialization in cell therapeutics. The company has a unique Cymerus technology which deals with the complexity and challenges of manufacturing the.
12/15/18 - Diabetes Centre inaugurated at Suntreso Hospital [Syrian Arab News Agency]
A Diabetes Support Centre has been inaugurated at the Suntreso Government Hospital in Kumasi. The Danish Embassy in Ghana, facilitated the construction of the centre which was built by Novo Nordisk, a Danish pharmaceutical company with expertise in diabetes care. At a ceremony to officially open the centre, the Ashanti Regional Director of Health S
12/15/18 - Dr. Jin Kim, Internationally Influential Periodontist, Offers FDA-Cleared LANAP Laser Therapy for Periodontal Disease in Chino Hills, CA [Tehran Times (Iran)]
-Jin Y. Kim, a leading board-certified periodontist who has dedicated his career to learning and contributing to the latest in periodontal care welcomes people withperiodontal diseasein Chino Hills, CA, to take advantage of LANAP, the FDA- cleared laser gum therapy treatment he offers. When patients work with Dr. Kim to properly address their gum d
12/15/18 - DRAP fails to check corruption, unethical marketing practices by Pharma trade and industry
Drug Regulatory Authority of Pakistan which is one of the regulatory bodies and monitoring agencies to check corruption and unethical marketing practices by the pharma trade and industry has miserably failed to perform its duties. Farhat Moazam and approved by the Federal Government as well as Pakistan Medical and Dental Council many years ago but
12/15/18 - Family of Lakewood toddler with brain tumor desperate for unapproved drug []
LAKEWOOD, Colo. 2018 Elijah Gonzalez can only eat through a feeding tube. "The only drug that could really help him save his live is called tazemetostat manufactured by Epizyme," said Elijah's father Cesar Gonzalez. Yet the 41- year old Lakewood dad said the Massachusetts- based pharmaceutical company Epizyme has not been willing to make its exp
12/15/18 - Generex Biotechnology Receives IND Approval From FDA For Phase II Combination Study Using AE37 Plus Keytruda (Pembrolizumab) For The Treatment Of Triple Negative Breast Cancer [Syrian Arab News Agency]
Generex Biotechnology Corporation today announced that the FDA had reviewed the companys investigational new drug application and given notification that the study can proceed. The study: A Phase II Clinical Trial of Pembrolizumab in Combination with the AE37 Peptide Vaccine in Patients with Metastatic Triple Negative Breast Cancer, is sponsored by
12/15/18 - Global Anti-Counterfeit Pharmaceutical Packaging Market to Witness Significant Revenue Growth Through 2026: Global Anti-counterfeit Pharmaceutical Packaging Market: Latin America Market to Expand at Rapid Pace in Future
Valley Cottage, NY 12/15/2018 Future Market Insights has published a new report, which is titled, "Anti-counterfeit Pharmaceutical Packaging Market: APEJ Regional Market to Register Healthy CAGR During the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016-2026." The widespread counterfeiting of medicines has forced th
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
Pharmacy Spanish
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement